Clinical Trials Browser

Terminated × Papillomavirus Infections × Head & Neck × Clear all

NCT02827838 2025-03-17

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Phase EARLY_PHASE1 Terminated

17 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT03258008 2022-12-16

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

Phase 2 Terminated

3 enrolled 7 charts

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT01891695 2022-10-12

OPSCC N0 Nodal Control With Reduced IMRT

Phase NA Terminated

1 enrolled 4 charts

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT04015336 2022-02-24

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Phase 2 Terminated

1 enrolled 6 charts

Oropharyngeal Neoplasms, Papillomavirus Infections

NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Phase 2 Terminated

1 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections